Ligand Pharmaceuticals
LGND
LGND
293 hedge funds and large institutions have $3.35B invested in Ligand Pharmaceuticals in 2017 Q3 according to their latest regulatory filings, with 52 funds opening new positions, 114 increasing their positions, 81 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
293
Holders Change
+28
Holders Change %
+10.57%
% of All Funds
7.32%
Holding in Top 10
10
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+42.86%
% of All Funds
0.25%
New
52
Increased
114
Reduced
81
Closed
20
Calls
$11.2M
Puts
$19.3M
Net Calls
-$8.01M
Net Calls Change
-$29.2M
Top Buyers
| 1 |
Bank of America
Charlotte,
North Carolina
|
+$57.7M |
| 2 |
GT
Glenmede Trust
Philadelphia,
Pennsylvania
|
+$42.5M |
| 3 |
BlackRock
New York
|
+$35.6M |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
+$21.7M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$17.8M |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
SI
301
Stephens Inc
Little Rock,
Arkansas
| – | -$221K | -2,919 | Closed |
|
|
VHAM
302
Van Hulzen Asset Management
El Dorado Hills,
California
| – | -$208K | -2,749 | Closed |
|
|
JG
303
Jefferies Group
New York
| – | -$206K | -2,725 | Closed |
|
|
PM
304
Parametrica Management
Wanchai,
Hong Kong
| – | -$206K | -2,717 | Closed |
|
305
Jane Street
New York
| – | -$205K | -2,706 | Closed |
|
|
SGK
306
Steigerwald Gordon & Koch
Leesburg,
Virginia
| – | -$202K | -2,671 | Closed |
|
|
MF
307
Magnetar Financial
Evanston,
Illinois
| – | -$201K | -2,655 | Closed |
|
|
SQA
308
Simon Quick Advisors
Morristown,
New Jersey
| – | -$20K | -261 | Closed |
|
|
SPIA
309
Steward Partners Investment Advisory
New York
| – | -$3K | -48 | Closed |
|
310
Northwestern Mutual Wealth Management
Milwaukee,
Wisconsin
| – | -$3K | -45 | Closed |
|